Literature DB >> 12431225

Characterization of a novel NCAM ligand with a stimulatory effect on neurite outgrowth identified by screening a combinatorial peptide library.

Lars C B Rønn1, Marianne Olsen, Vladislav Soroka, Søren ØStergaard, Steen Dissing, Flemming M Poulsen, Arne Holm, Vladimir Berezin, Elisabeth Bock.   

Abstract

The neural cell adhesion molecule, NCAM, plays a key role in neural development and plasticity mediating cell adhesion and signal transduction. By screening a combinatorial library of synthetic peptides with NCAM purified from postnatal day 10 rat brains, we identified a nonapeptide, termed NCAM binding peptide 10 (NBP10) and showed by nuclear magnetic resonance analysis that it bound the NCAM IgI module of NCAM. NBP10 modulated cell aggregation as well as neurite outgrowth induced specifically by homophilic NCAM binding. Moreover, both monomeric and multimeric forms of NBP10 stimulated neurite outgrowth from primary hippocampal neurons. The neurite outgrowth response to NBP10 was inhibited by a number of compounds previously shown to inhibit neurite outgrowth induced by homophilic NCAM binding, including voltage-dependent calcium channel antagonists, suggesting that NBP10 induced neurite outgrowth by activating a signal transduction pathway similar to that activated by NCAM itself. Moreover, an inhibitor of intracellular calcium mobilization, TMB-8, prevented NBP10-induced neurite outgrowth suggesting that NCAM-dependent neurite outgrowth also requires mobilization of calcium from intracellular calcium stores in addition to calcium influx from extracellular sources. By single-cell calcium imaging we further demonstrated that NBP10 was capable of inducing an increase in intracellular calcium in PC12E2 cells. Thus, the NBP10 peptide is a new tool for the study of molecular mechanisms underlying NCAM-dependent signal transduction and neurite outgrowth, and could prove to be a useful modulator of regenerative processes in the peripheral and central nervous system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431225     DOI: 10.1046/j.1460-9568.2002.02242.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  7 in total

Review 1.  NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.

Authors:  Glenn Dallérac; Claire Rampon; Valérie Doyère
Journal:  Neurochem Res       Date:  2013-03-14       Impact factor: 3.996

2.  Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.

Authors:  Ravi Anand; Michael Seiberling; Thierry Kamtchoua; Rolf Pokorny
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 3.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

4.  A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD.

Authors:  M Jain; J I Vélez; M T Acosta; L G Palacio; J Balog; E Roessler; D Pineda; A C Londoño; J D Palacio; A Arbelaez; F Lopera; J Elia; H Hakonarson; C Seitz; C M Freitag; H Palmason; J Meyer; M Romanos; S Walitza; U Hemminger; A Warnke; J Romanos; T Renner; C Jacob; K-P Lesch; J Swanson; F X Castellanos; J E Bailey-Wilson; M Arcos-Burgos; M Muenke
Journal:  Mol Psychiatry       Date:  2011-05-24       Impact factor: 15.992

Review 5.  Latrophilin-3 disruption: Effects on brain and behavior.

Authors:  Samantha L Regan; Michael T Williams; Charles V Vorhees
Journal:  Neurosci Biobehav Rev       Date:  2021-05-19       Impact factor: 9.052

Review 6.  NCAM mimetic peptides: Pharmacological and therapeutic potential.

Authors:  Vladimir Berezin; Elisabeth Bock
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

7.  Pharmacology of cell adhesion molecules of the nervous system.

Authors:  Darya Kiryushko; Elisabeth Bock; Vladimir Berezin
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.